Ana L. Portillo
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
IL-21-reprogrammed Vδ1 T cells exert killing against solid tumors which is enhanced by CAR arming for off-the-shelf immunotherapy.
Journal: Oncoimmunology
Published: September 25, 2025
Biological Sex Influences Human Bystander CD8+ T Cell Activation.
Journal: European journal of immunology
Published: November 20, 2024
CD56 does not contribute to the antitumor, tissue homing, and glycolytic capacity of human NK cells.
CD56 does not contribute to the antitumor, tissue homing, and glycolytic capacity of human NK cells.
Journal: Journal of leukocyte biology
Published: September 02, 2024
The impact of oral cannabis consumption during pregnancy on maternal spiral artery remodelling, fetal growth and offspring behaviour in mice.
Journal: EBioMedicine
Published: April 03, 2024
Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment.
Journal: Immunological reviews
Published: March 09, 2024
Natural Killer Cell-Derived Interferon-γ Regulates Macrophage-Mediated Immunopathology During Viral Infection.
Journal: The Journal of infectious diseases
Published: December 18, 2022
Bystander activated CD8+ T cells mediate neuropathology during viral infection via antigen-independent cytotoxicity.
Journal: Nature communications
Published: February 09, 2022
Production of human CAR-NK cells with lentiviral vectors and functional assessment in vitro.
Journal: STAR protocols
Published: November 26, 2021
Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity.
Journal: The European respiratory journal
Published: August 11, 2021
Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells.
Journal: Communications biology
Published: January 28, 2021
Expanded human NK cells from lung cancer patients sensitize patients' PDL1-negative tumors to PD1-blockade therapy.
Journal: Journal for immunotherapy of cancer
Published: December 11, 2020
Last Updated: 09/26/2026